Clinical trials
Active, not recruiting Phase 2 Leukemia, Myelomonocytic, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| City of Hope Medical Center | 3 |
| Asan Medical Center | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Novartis Pharmaceuticals | 1 |
| University of Utah | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 13 |
| Myelodysplastic Syndromes | 9 |
| Leukemia, Myeloid, Acute | 6 |
| Myeloproliferative Disorders | 6 |
| Primary Myelofibrosis | 4 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Leukemia | 3 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3 |
| Myelodysplastic-Myeloproliferative Diseases | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.